🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Fadraciclib, CYC140, Sapacitabine, Seliciclib

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of medicines for treating cancer and other proliferative diseases. The company's key development programs include fadraciclib, CYC140, Sapacitabine, and seliciclib, targeting various forms of cancer and other conditions.

Tags: CDK inhibitors, biopharmaceutical, cancer treatment, clinical trials, proliferative diseases

Symbol: CYCC

Recent Price: $0.37

Industry: Biotechnology

CEO: Mr. Spiro George Rombotis

Sector: Healthcare

Employees: 12

Address: 200 Connell Drive, Berkeley Heights, NJ 07922

Phone: 908 517 7330

Last updated: 2024-12-31